Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare ACO Plan Could Improve Rx Compliance But Lacks Guidance On Drug Management Policies

Executive Summary

Medicare-sanctioned accountable care organizations could significantly improve drug adherence among beneficiaries as a way to prevent more costly medical interventions later, under a widely-anticipated CMS proposal.

You may also be interested in...



Medicare ACO Cost Incentives For Part B-To-D Rx Shifts Worry Stakeholders

CMS should look for ways to ensure that financial incentives for Medicare accountable care organizations do not promote inappropriate shifts in prescribing from the Part B benefit to Part D, biotech and clinician groups urge in comments filed with the agency June 6.

Medicare ACO Cost Incentives For Part B-To-D Rx Shifts Worry Stakeholders

CMS should look for ways to ensure that financial incentives for Medicare accountable care organizations do not promote inappropriate shifts in prescribing from the Part B benefit to Part D, biotech and clinician groups urge in comments filed with the agency June 6.

Booz VP Advises Pharma: Show Value To Gain Market Access

Pharma's rapidly changing commercial environment has forced companies to re-think their traditional approaches to marketing.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS053294

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel